Publications by authors named "Raquel Marin-Gorricho"
Article Synopsis
- Inborn errors of metabolism are diverse orphan diseases treated mainly through dietary changes and orphan drugs, but research is limited due to the small patient population.
- A study analyzed the effectiveness of nine different orphan drugs on 15 pediatric patients, revealing mixed results in symptom improvement while showcasing reasonable treatment tolerance.
- The high cost of these drugs raises questions about their cost-effectiveness, especially given the varying effectiveness and limited clinical evidence available.
Introduction: Inborn errors of metabolism are a highly heterogeneous group of orphan diseases. Diet therapy and enzyme and coenzyme replacement are the most frequently used treatment. There are few patients and published studies about inborn errors of metabolism.
View Article and Find Full Text PDFAim: To analyze the effects of subcutaneous or intravenous rituximab + lymphokine-activated killer cells, obinutuzumab or ibrutinib on natural killer (NK) cell levels in chronic lymphocytic leukemia and follicular lymphoma patients.
Patients & Methods: The distribution of peripheral blood NK cells of 31 patients was analyzed by flow cytometry.
Results: We detected a decrease of NK cells in peripheral blood below normal range after obinutuzumab treatment.
Background: Treatment based on nab-paclitaxel plus gemcitabine is one of the standard treatments for locally advanced or metastatic pancreatic adenocarcinoma. Not much information is available about its use in clinical practice. Looking for prognostic markers may aid in improving treatment plans for patients.
View Article and Find Full Text PDFObjective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to determine anticholinergic risk using the ACB and ARS scales; and to determine if these patients use any type of benzodiazepine.
Method: A descriptive observational study of 256 HIV patients 50 years or older.
Results: 73.